Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hibiscus tea for Moms-to-Be? tiny study tests safety and taste

NCT ID NCT07175597

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This pilot study tested whether a daily hibiscus drink is acceptable and tolerable for pregnant women in their second trimester. Ten women drank it for four weeks and reported on taste and any stomach issues. Researchers also checked blood pressure and blood markers before and after. The goal was to see if this natural drink could be a safe option for supporting pregnancy health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hibiscus sabdariffa drink (providing 9.6 mg of anthocyanins daily)
What this could lead to
If the drink is well-tolerated and shows positive effects on blood pressure, it could point toward a natural dietary supplement to support maternal health during pregnancy.
What could go wrong
This is a very small pilot study with only 10 participants and no control group, so results may not apply to all pregnant women. The drink's safety and effectiveness need much larger trials to confirm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Apr 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women in the second trimester of pregnancy (14 to 28 gestation weeks) * Age 18 to 35 years * Blood pressure \<140/90 mmHg Exclusion Criteria: * Multiple or high-risk pregnancy * Hypertensive disorder in previous pregnancies * Body mass index \>32 kg/m2 * Present chronic diseases

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant woman are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MEDOMAI

    Cuernavaca, Morelos, 62280, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.